(Q43597424)

25 November 2017

title

Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats (English)

1 reference

25 November 2017

Samnegård E

1

1 reference

25 November 2017

Akhter MP

series ordinal

2

1 reference

25 November 2017

Recker RR

series ordinal

3

1 reference

25 November 2017

publication date

1 April 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

28

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

414-422

1 reference

Effect of parathyroid hormone (hPTH[1-84]) treatment on bone mass and strength in ovariectomized rats

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Elastic properties of cancellous bone: measurement by an ultrasonic technique

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

A continuous wave technique for the measurement of the elastic properties of cortical bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Elastic modulus of trabecular bone material

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Calcium and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Estrogen dose required to maintain parathyroid hormone mediated bone gain in osteopenic ovariectomized rats is probably higher than in preventive treatment with estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Epidemiology of hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Global public health and the information superhighway. Doctors and students need computer training

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Nondestructive measurement of bone mineral in femurs from ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Prevention of spinal osteoporosis in oophorectomised women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Perspective. How many women have osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Menopausal estrogen therapy and hip fractures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Structure-activity relationships of various bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Ultrasonic velocity as a predictor of strength in bovine cancellous bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Effect of body weight on osteopenia in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Local bone turnover in the metaphysis of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900408-2

7 January 2021

10.1016/S8756-3282(01)00408-2

Identifiers

DOI

1 reference

release_wln2sss4mnf5nmof4r6jpkje2a

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wln2sss4mnf5nmof4r6jpkje2a

24 November 2022

mapped directly with Wikidata item

1 reference